VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹54 Cr | ₹57 Cr | ₹48 Cr | ₹54 Cr | ₹58 Cr |
What is the latest Total Current Liabilities ratio of VIMTA LABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹57 Cr |
| Mar2022 | ₹48 Cr |
| Mar2021 | ₹54 Cr |
| Mar2020 | ₹58 Cr |
How is Total Current Liabilities of VIMTA LABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹54 Cr | -5.60 | |
| Mar2023 | ₹57 Cr | 19.95 | |
| Mar2022 | ₹48 Cr | -11.43 | |
| Mar2021 | ₹54 Cr | -6.34 | |
| Mar2020 | ₹58 Cr | - | |
Compare Total Current Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,848.6 Cr | 3.1% | -6% | -18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 3.1% |
-6% |
-18.9% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses